Procter & Gamble Health Ltd
NSE:PGHL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Procter & Gamble Health Ltd
Depreciation & Amortization
Procter & Gamble Health Ltd
Depreciation & Amortization Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Procter & Gamble Health Ltd
NSE:PGHL
|
Depreciation & Amortization
-₹227.9m
|
CAGR 3-Years
8%
|
CAGR 5-Years
4%
|
CAGR 10-Years
0%
|
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Depreciation & Amortization
-₹19.6B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-11%
|
|
|
Cipla Ltd
NSE:CIPLA
|
Depreciation & Amortization
-₹11.4B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-6%
|
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Depreciation & Amortization
-₹28.3B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-9%
|
|
|
Lupin Ltd
NSE:LUPIN
|
Depreciation & Amortization
-₹13.2B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-11%
|
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Depreciation & Amortization
-₹8.1B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-13%
|
|
Procter & Gamble Health Ltd
Glance View
In the vast landscape of healthcare, Procter & Gamble Health Ltd. carves its niche by blending science with daily life, transforming mundane routines into healthier lifestyles. Originally known for its parent company’s deep roots in consumer goods, P&G Health Ltd. has transitioned seamlessly into the pharmaceutical domain, focusing on over-the-counter (OTC) health products and supplements. Its journey is one of leveraging brand trust and an extensive distribution network to ensure that essential health solutions are accessible to consumers around the globe. P&G Health's emphasis on consumer awareness and education propels its growth, as it capitalizes on the modern consumer’s desire for self-care and proactive health management. At the heart of its business model lies a portfolio of products that spans various health categories, encapsulating vitamins, minerals, and supplements that address widespread health needs such as digestive wellness and immunity. The company thrives on innovation and strategic collaboration, utilizing a mix of in-house research alongside partnerships to remain at the forefront of consumer health trends. Revenue streams are buoyed by the strength of its established global market presence and regional expertise, ensuring adaptability across diverse economic landscapes. By catering to both established and emerging markets, Procter & Gamble Health Ltd. sustains its growth momentum, continuously refining its product offerings to meet the dynamic demands of health-conscious consumers.
See Also
What is Procter & Gamble Health Ltd's Depreciation & Amortization?
Depreciation & Amortization
-227.9m
INR
Based on the financial report for Dec 31, 2025, Procter & Gamble Health Ltd's Depreciation & Amortization amounts to -227.9m INR.
What is Procter & Gamble Health Ltd's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 10Y
0%
Over the last year, the Depreciation & Amortization growth was 10%. The average annual Depreciation & Amortization growth rates for Procter & Gamble Health Ltd have been 8% over the past three years , 4% over the past five years .